373
views
views
Low-dose naltrexone had its very first human trial conducted in 2007, and since that time, it has been proved beneficial for the treatment of various medical conditions. Effectiveness in treating fibromyalgia, multiple sclerosis, Crohn’s, and lupus have been recorded in a number of clinical studies.
Things you must know about LDN therapy
Low-dose naltrexone had its very first human trial conducted in 2007, and since that time, it has been proved beneficial for the treatment of various medical conditions. Effectiveness in treating fibromyalgia, multiple sclerosis, Crohn’s, and lupus have been recorded in a number of clinical studies.